25-Year study of lung fibrosis following carmustine therapy for brain tumor in childhood [10]

Sudhir Lohani; B. Ronan O'Driscoll; Ashley A. Woodcock

doi:10.1378/chest.126.3.1007

25-Year study of lung fibrosis following carmustine therapy for brain tumor in childhood [10]

Sudhir Lohani, B. Ronan O'Driscoll, Ashley A. Woodcock

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1007
Journal	Chest
Volume	126
Issue number	3
DOIs	https://doi.org/10.1378/chest.126.3.1007
Publication status	Published - Sept 2004

Keywords

Adolescent
Adult
adverse effects: Antineoplastic Agents, Alkylating
drug therapy: Brain Neoplasms
adverse effects: Carmustine
Child
Disease Progression
Dose-Response Relationship, Drug
Follow-Up Studies
Humans
chemically induced: Pulmonary Fibrosis
Risk Factors

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1378/chest.126.3.1007

Cite this

@article{ed7aad6653e948bfbd2187d27624b5cc,

title = "25-Year study of lung fibrosis following carmustine therapy for brain tumor in childhood [10]",

keywords = "Adolescent, Adult, adverse effects: Antineoplastic Agents, Alkylating, drug therapy: Brain Neoplasms, adverse effects: Carmustine, Child, Disease Progression, Dose-Response Relationship, Drug, Follow-Up Studies, Humans, chemically induced: Pulmonary Fibrosis, Risk Factors",

author = "Sudhir Lohani and O'Driscoll, {B. Ronan} and Woodcock, {Ashley A.}",

year = "2004",

month = sep,

doi = "10.1378/chest.126.3.1007",

language = "English",

volume = "126",

pages = "1007",

journal = "Chest",

issn = "0012-3692",

publisher = "American College of Chest Physicians",

number = "3",

}

TY - JOUR

T1 - 25-Year study of lung fibrosis following carmustine therapy for brain tumor in childhood [10]

AU - Lohani, Sudhir

AU - O'Driscoll, B. Ronan

AU - Woodcock, Ashley A.

PY - 2004/9

Y1 - 2004/9

KW - Adolescent

KW - Adult

KW - adverse effects: Antineoplastic Agents, Alkylating

KW - drug therapy: Brain Neoplasms

KW - adverse effects: Carmustine

KW - Child

KW - Disease Progression

KW - Dose-Response Relationship, Drug

KW - Follow-Up Studies

KW - Humans

KW - chemically induced: Pulmonary Fibrosis

KW - Risk Factors

U2 - 10.1378/chest.126.3.1007

DO - 10.1378/chest.126.3.1007

M3 - Article

SN - 0012-3692

VL - 126

SP - 1007

JO - Chest

JF - Chest

IS - 3

ER -